This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Nov;10(6):413-6.

doi: 10.1007/s11910-010-0133-3.

Does rasagiline have a disease-modifying effect on Parkinson's disease?

Shyamal H Mehta¹, John C Morgan, Kapil D Sethi

Affiliations

PMID: 20711692
DOI: 10.1007/s11910-010-0133-3

Comment

Does rasagiline have a disease-modifying effect on Parkinson's disease?

Shyamal H Mehta et al. Curr Neurol Neurosci Rep. 2010 Nov.

. 2010 Nov;10(6):413-6.

doi: 10.1007/s11910-010-0133-3.

Authors

Shyamal H Mehta¹, John C Morgan, Kapil D Sethi

Affiliation

¹ Movement Disorders Program, Medical College of Georgia, Augusta, GA 30912, USA.

PMID: 20711692
DOI: 10.1007/s11910-010-0133-3

No abstract available

PubMed Disclaimer

Comment on

A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators. Olanow CW, et al. N Engl J Med. 2009 Sep 24;361(13):1268-78. doi: 10.1056/NEJMoa0809335. N Engl J Med. 2009. PMID: 19776408 Clinical Trial.

References

1. Mov Disord. 2008 Apr 30;23(6):784-9 - PubMed
1. N Engl J Med. 2009 Sep 24;361(13):1304-6 - PubMed
1. Neurology. 2010 Apr 6;74(14):1143-8 - PubMed
1. N Engl J Med. 1989 Nov 16;321(20):1364-71 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer